COVID19
+2
At-Home COVID-19 Antibody Test Usability Assessment & Behavior Change Study
Sponsored by ProofPilot
About this trial
Last updated 5 years ago
Study ID
2458
Status
Unknown status
Type
Interventional
Phase
N/A
Placebo
No
Accepting
18 to 100 Years
All
Trial Timing
Ended 5 years ago
What is this trial about?
Radish Health and ProofPilot in coordination with Sanesco are running this study to help
establish whether the Premier Biotech COVID-19 IgG/IgM Rapid Test Cassette (Whole
Blood/Serum/Plasma Authorized for distribution under emergency use authorization - though not
yet FDA reviewed) can be conducted effectively at home to detect COVID-19 antibodies among
individuals who have tested positive, or suspect they have previous contracted from COVID-19
and recovered. The study also aims to examine how the results of those tests change
social-distancing behaviors and general anxiety over 8 weeks post-test.
What are the participation requirements?
Inclusion Criteria
- Reside and Currently in New York City
- Does not have a blood clotting disease
- Is not abnormally queasy about taking a blood sample
- Not on any blood thinning medications
- Able to consent
- Willingness to take a blood sample
- Confirmed of highly likely past infection with COVID-19 over 14 days ago and fully recovered
Locations
Location
Status
Recruiting